Heterocycles: Design, Synthesis and Biological Evaluation, 4th Edition
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 843
Special Issue Editors
Interests: medicinal chemistry; drug interactions; molecular docking; plasma proteins; biological activity; drug design; spectroscopic methods; computational chemistry
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; organic synthesis; heterocycles; drug design; pharmaceutics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Heterocycles constitute a major class of organic compounds. They have applications in many fields of science, such as chemistry, pharmacy, and medicine. As many organic compounds with heterocyclic rings display biological activity, including anticancer, antibacterial, and anti-inflammatory functions, they represent robust drug candidates. In preclinical research, the design of more effective and selective novel compounds with promising biological activities and minimal side effects is critical, as is the development of new strategies and a greater variety of therapeutic options. Other areas of importance include in silico approaches to the design and development of more accessible and greener synthesis methods. These areas offer ample opportunity for extensive research into heterocycles.
This Special Issue aims to present recent studies on the design, synthesis, and biological evaluation of heterocycle compounds. Researchers working in this field are invited to submit original research papers and review articles to this Special Issue.
Dr. Edward Krzyżak
Dr. Piotr Świątek
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heterocycles
- organic synthesis
- drug design
- biological activity
- medicinal chemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
